Related Experiment Video
Updated: Jun 24, 2026
08:49
External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
Non-diabetic macrosomia: an obstetric dilemma
Summary
Fetal macrosomia, or excessively large babies, poses significant risks like shoulder dystocia and birth injuries. Current methods for predicting and managing non-diabetic fetal macrosomia lack clear consensus and effective ante-partum strategies.
Area of Science:
- Obstetrics and Gynecology
- Perinatal Medicine
- Fetal Development
Background:
- Fetal macrosomia presents ongoing obstetric challenges, with rising incidence and associated risks of shoulder dystocia, fetal/maternal injury, and medicolegal issues.
- Non-diabetic fetal macrosomia remains an obstetric dilemma due to imprecise ante-partum prediction and a lack of management consensus, with accurate diagnosis often retrospective.
- The risk of shoulder dystocia significantly increases with higher birth weights, yet a substantial proportion of cases occur in infants not classified as macrosomic.
Purpose of the Study:
- To review the challenges and current understanding of fetal macrosomia in non-diabetic pregnancies.
- To evaluate the effectiveness of current diagnostic and management strategies for fetal macrosomia and associated risks.
- To highlight the limitations in prenatal prediction and the impact on clinical decision-making.
Main Methods:
- Literature review of existing studies on fetal macrosomia, shoulder dystocia, and birth injuries.
- Analysis of incidence rates, risk factors, and diagnostic accuracy of current methods (ultrasound, clinical assessment).
- Examination of management options including induction of labor and cesarean delivery, and their outcomes.
Main Results:
- Prenatal diagnosis of fetal macrosomia is imprecise, with poor predictive value from risk factors and ultrasound.
- Shoulder dystocia risk escalates with birth weight, but many cases occur below 4,500g.
- Interventions like labor induction and prophylactic cesarean delivery have not demonstrated a reduction in shoulder dystocia for non-diabetic patients.
Conclusions:
- Accurate ante-partum prediction and effective management of non-diabetic fetal macrosomia remain elusive.
- Current diagnostic tools and interventions have limitations, necessitating further research into improved prediction and management protocols.
- Cesarean section and labor induction carry their own risks of morbidity, mortality, and increased costs, complicating clinical decisions.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...